There was also a positive trend toward pain improvement with CDK4/6 inhibitors plus ET.
← all excerpts
The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis.
1
—
—
There was also a positive trend toward pain improvement with CDK4/6 inhibitors plus ET.